openPR Logo
Press release

Heart Pump Devices Market to Witness Comprehensive Growth by 2026

08-16-2018 08:27 PM CET | Health & Medicine

Press release from: Transparency Market Research

Heart Pump Devices Market to Witness Comprehensive Growth

Heart pump devices are used to improve the circulation of blood in the body. These are used for several conditions, such as, when a patient is not eligible for a heart transplant, during or after surgery, until a patient’s heart recovers, or while waiting for a heart transplant. Ventricular assist device is a commonly used heart pump. Several types of heart pumps are available, such as, right ventricle assist device (RVAD), left ventricular assist device (LVAD), and biventricular assist device (BiVAD). The left ventricular assist device is a commonly used device and helps the left ventricle pump blood to the aorta. The right ventricle assist device is used only for short-term support and helps the right ventricle pump blood to the pulmonary artery.

Factors such as rising incidence of cardiovascular diseases, growing geriatric population with weak disease resistance, decreasing number of donor heart, and high prevalence of unhealthy lifestyle are the key drivers of the global Heart Pump Devices Market. According to HeartWare International Inc., there are fewer than 4,000 donor hearts available worldwide each year. Other factors such as regulatory approval of several new and advanced heart pump devices, rising health care expenditure are propelling the growth of the market. For instance, in April 2018, Abiomed, Inc. received US FDA’s approval for Impella CP heart pump. On the other hand, high product prices are likely to hamper the global heart pump devices market during the forecast period.

The heart pump devices market can be segmented based on product type, application, end-user, and geography. In terms of product type, the heart pump devices market can be classified into ventricular assist devices, intra-aortic balloon pumps, and total artificial heart. Ventricular assist devices can be further classified into right ventricle (RVAD), left ventricle (LVAD), and biventricular assist device (BiVAD). Based on application, the heart pump devices market can be divided into bridge-to-transplantation, destination therapy, and other therapies. In terms of end-user, the heart pump devices market can be categorized into hospitals, clinics, cardiac centers, and ambulatory surgery centers. In terms of geography, the global heart pump devices market can be classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45147

North America dominates the global heart pump devices market. Factors such as technological advancements, increased number of cardiovascular diseases, and rise in demand for artificial heart are anticipated to boost the heart pump devices in the region during the forecast period. According to a health care practitioner from California, there is an increasing occurrence of several cardiovascular diseases among the adult population. According to the Centers for Disease Control and Prevention, heart diseases account for approximately 610,000 deaths in the U.S. each year. Europe is the second-leading market for heart pump devices. The heart pump devices market in Asia Pacific is expected to expand at a rapid pace during the forecast period due to growth of elderly population in the country like Japan, prevalence of unhealthy lifestyle among people, growing burden of cardiovascular diseases, developing health care infrastructure in the region. According to OECD estimation, cardiovascular diseases are the leading cause of deaths in Asia Pacific, with over 9.3 million deaths caused due to such diseases in the region in 2012. Cardiovascular diseases accounted for about 33% of the total number of deaths in Asia Pacific in 2012.

Major players operating in the heart pump devices market include Medtronic plc, Abbott Laboratories, Thoratec Corporation, Jarvik Heart, Inc., HeartWare International Inc., Terumo Europe NV, Berlin Heart GmbH, and Getinge AB.

View Report -

https://www.transparencymarketresearch.com/heart-pump-devices-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Heart Pump Devices Market to Witness Comprehensive Growth by 2026 here

News-ID: 1183914 • Views:

More Releases from Transparency Market Research

Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights for the USD 15.9 Bn Market 2022-2031
Handheld Marijuana Vaporizer Market Key Drivers, Market Research, and Insights f …
The global handheld marijuana vaporizer market has witnessed remarkable growth in recent years, attributed to the increasing acceptance of medicinal marijuana and the demand for convenient and discreet consumption methods. Valued at US$ 5 billion in 2021, the market is projected to surge at a CAGR of 13.4% to reach US$ 15.9 billion by 2031. This article delves into the factors driving this growth, the evolving market landscape, and the
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And Competitors
Disinfectant Wipes Market Forecast 2020-2030 - Market Size, Drivers, Trends, And …
The COVID-19 pandemic has precipitated a remarkable surge in the demand for disinfectant products, with a notable emphasis on disinfectant wipes as an essential tool in maintaining hygiene and preventing the spread of pathogens. This research report delves into the multifaceted landscape of the disinfectant wipes market, elucidating key trends, drivers, and innovations shaping the industry. 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐫𝐞𝐩𝐨𝐫𝐭 @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=70359 Key Players and Market Developments Key players
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn

All 5 Releases


More Releases for Heart

Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF).
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an